Literature DB >> 22001794

Inclusion complexes of isoflavones with two commercially available dendrimers: Solubility, stability, structures, release behaviors, cytotoxicity, and anti-oxidant activities.

Chen Zhao1, Yitong Wang, Yunzhang Su, Hongfeng Zhang, Lingxiao Ding, Xiaofeng Yan, Di Zhao, Naimin Shao, Xiyun Ye, Yiyun Cheng.   

Abstract

We prepared and characterized the inclusion complexes of daidzein with poly(amidoamine) (PAMAM) and poly(propylene imine) (PPI) dendrimers. Aqueous solubility of daidzein was significantly enhanced by both PAMAM and PPI (186- and 650-fold at 0.36mM, respectively). Daidzein in G3 PAMAM solution is more stable than that in G4 PPI. NMR studies reveal the encapsulation of daidzein within the interior cavities of PPI through hydrophobic interactions. Daidzein exhibits a slower release behavior from PPI than that from PAMAM. PPI/daidzein complex is much more toxic than PAMAM/daidzein complex on several cell lines. PAMAM/daidzein complexes showed similar protective effect on oxidative stress-induced cytotoxicity as compared to free daidzein. These results suggest that the inclusion of daidzein with dendrimer can effectively improve the solubility, prolong the delivery, and maintain the anti-oxidant activity of daidzein. This research provides new insights into dendrimer-based drug delivery systems and will be helpful for the design of novel dendrimer/drug formulations.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001794     DOI: 10.1016/j.ijpharm.2011.09.044

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

1.  Increased Active Tumor Targeting by An αvβ3-Targeting and Cell-Penetrating Bifunctional Peptide-Mediated Dendrimer-Based Conjugate.

Authors:  Pengkai Ma; Huajun Yu; Xuemei Zhang; Hongjie Mu; Yongchao Chu; Ling Ni; Pingping Xing; Yiyun Wang; Kaoxiang Sun
Journal:  Pharm Res       Date:  2016-11-15       Impact factor: 4.200

2.  Assessment of Pharmacokinetic Parameters of Daidzein-Containing Nanosuspension and Nanoemulsion Formulations After Oral Administration to Rats.

Authors:  Esra Demirtürk; Afife Büşra Ugur Kaplan; Meltem Cetin; Kübra Akıllıoğlu; Meltem Dönmez Kutlu; Seda Köse; Fazilet Aksu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2022-01-12       Impact factor: 2.441

3.  Changes in the anti-inflammatory activity of soy isoflavonoid genistein versus genistein incorporated in two types of cyclodextrin derivatives.

Authors:  Corinatiulea Danciu; Codruta Soica; Erzsebet Csanyi; Rita Ambrus; Stefana Feflea; Camelia Peev; Cristina Dehelean
Journal:  Chem Cent J       Date:  2012-06-20       Impact factor: 4.215

4.  Poly(chitosan-ester-ether-urethane) Hydrogels as Highly Controlled Genistein Release Systems.

Authors:  Martyna Zagórska-Dziok; Patrycja Kleczkowska; Ewa Olędzka; Ramona Figat; Marcin Sobczak
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

5.  Formulation of Genistein-HP β Cyclodextrin-Poloxamer 188 Ternary Inclusion Complex: Solubility to Cytotoxicity Assessment.

Authors:  Ameeduzzafar Zafar; Nabil K Alruwaili; Syed Sarim Imam; Omar Awad Alsaidan; Faisal K Alkholifi; Khalid Saad Alharbi; Ehab M Mostafa; Abdullah S Alanazi; Sadaf Jamal Gilani; Arafa Musa; Sultan Alshehri; Alenazy Rawaf; Ali Alquraini
Journal:  Pharmaceutics       Date:  2021-11-24       Impact factor: 6.525

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.